Literature DB >> 22484280

Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.

Federico Martinón-Torres1, Nazareth Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Sonia Pértega-Díaz, María Teresa Seoane-Pillado, Jorge Aboal Viñas, María San-Martín.   

Abstract

Rotavirus vaccines were licensed in Spain between late 2006 and early 2007. Rotavirus vaccination was recommended but not reimbursed by the Spanish National Health System. Significant coverage rates have been reached in Galicia, with an average of 47% since the period July 2007-June 2008. We aim to explore eventual variations in the incidence of hospitalizations for acute gastroenteritis (AGE) among children < 5 y of age before and after vaccine introduction. The annual and monthly hospitalization rates for rotavirus-related AGE and all cause AGE, before and after rotavirus vaccine introduction, were calculated by using the official surveillance system for hospital data. The annual hospitalization rates for rotavirus-related AGE in children < 5 y of age decreased by 14.8% for the period July 2008 to June 2009 and by 44.5% for the period July 2009 to June 2010 as compared with the median rate of the pre-vaccination period (July 2003 to June 2007). The corresponding decreases for all cause AGE were 29.9% and 49.0%, respectively. In children < 12 mo of age a more marked decrease was observed. Compared with pre-vaccination years, a decrease in rotavirus-related and all cause AGE hospitalization rates was observed, with a greater decline in the July 2009 to June 2010 period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484280     DOI: 10.4161/hv.20178

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  4 in total

1.  Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain.

Authors:  Olga Redondo; Rosa Cano; Lorena Simón
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  A reverse evidence of rotavirus vaccines impact.

Authors:  Federico Martinón-Torres; Angela Aramburo; Nazareth Martinón-Torres; Miriam Cebey; María Teresa Seoane-Pillado; Lorenzo Redondo-Collazo; Jose Maria Martinón-Sánchez
Journal:  Hum Vaccin Immunother       Date:  2013-03-06       Impact factor: 3.452

3.  Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.

Authors:  Alejandro Orrico-Sanchez; Mónica López-Lacort; Silvia Pérez-Vilar; Javier Díez-Domingo
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

4.  Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.

Authors:  Susanne Hartwig; Matti Uhari; Marjo Renko; Perrine Bertet; Maria Hemming; Timo Vesikari
Journal:  BMC Health Serv Res       Date:  2014-12-11       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.